id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-258078-k7y8k1vx	Jang, Sukbin	Three cases of treatment with Nafamostat in elderly patients with COVID-19 pneumonia who need oxygen therapy	2020-05-26		.txt	text/plain	1481	62	43	We experienced clinical and radiologic improvement in COVID-19 patients with pneumonia treated by nafamostat. These cases were treated with nafamostat in elderly patients with pneumonia who progressed while using antiviral drugs in a high-risk group with limited sample size and not through a randomized control study, and Highly pathogenic coronavirus N protein aggravates lung injury by MASP-2-mediated complement over-activation The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak-an update on the status SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor Epidemiology, Pathogenesis, and Control of COVID-19 Thromboembolic risk and anticoagulant therapy in COVID-19 patients: Emerging evidence and call for action Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay	cache/cord-258078-k7y8k1vx.txt	txt/cord-258078-k7y8k1vx.txt
